--- title: "Bristol Myers buys Orum's blood cancer therapy for up to $180 mln" description: "Nov 6 (Reuters) - Bristol Myers Squibbhas acquired Orum Therapeutics’ experimental therapy to treat a type of blood cancer for a total value of up to $180 million, the privately held company said on M" type: "news" locale: "en" url: "https://longbridge.com/en/news/101774405.md" published_at: "2023-11-06T12:41:55.000Z" --- # Bristol Myers buys Orum's blood cancer therapy for up to $180 mln > Nov 6 (Reuters) - Bristol Myers Squibbhas acquired Orum Therapeutics’ experimental therapy to treat a type of blood cancer for a total value of up to $180 million, the privately held company said on Monday. Nov 6 (Reuters) - Bristol Myers Squibb (BMY.N) has acquired Orum Therapeutics’ experimental therapy to treat a type of blood cancer for a total value of up to $180 million, the privately held company said on Monday. The therapy, ORM-6151, which helps degrade a specific protein hard to treat previously, has received the U.S. Food and Drug Administration’s (FDA) clearance for an early stage study. The deal includes an upfront payment of $100 million and milestone payments, Orum said, without disclosing further details. ### Related Stocks - [BMY.US - Bristol Myers Squibb](https://longbridge.com/en/quote/BMY.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | 輝瑞在台灣開展新的 Elranatamab 研究,目標是收集現實世界的骨髓瘤數據 | 輝瑞公司(Pfizer Inc.,股票代碼:PFE)正在台灣啓動一項新的觀察性研究,以評估其多發性骨髓瘤藥物 elranatamab 在真實世界中的有效性。該研究旨在跟蹤患者的治療結果和治療模式,儘管尚未開始招募參與者。此舉預計將增強輝瑞的 | [Link](https://longbridge.com/en/news/276252273.md) | | 分析師對百時美施貴寶股票的評價 | 16 位分析師對百時美施貴寶(NYSE:BMY)進行了評估,結果顯示情緒不一,其中 4 位持看漲態度,3 位稍微看漲,8 位持中立態度,3 位稍微看跌,10 位持看跌評級。12 個月的平均目標價為 60.00 美元,較之前的 51.93 美 | [Link](https://longbridge.com/en/news/276477307.md) | | 陶冬:人民幣資產機會來了 科技自主牛市顯現 警示美債風險「黃金買貴不會買錯」 | 陶冬表示,人民幣資產機會已來,科技自主牛市顯現,當前是「資產為王」的時代,關注遠離央行控制的資產和科技突破。預計美聯儲將維持寬鬆政策,但短期內可能觀察。美債市場面臨風險,傳統零風險資產邏輯已被顛覆,需警惕未來利率可能降至 3% 左右。 | [Link](https://longbridge.com/en/news/276028666.md) | | 美國與印尼敲定貿易協議 輸美商品關税降至 19% | 美國與印尼達成貿易協議,印尼輸美商品關税降至 19%。協議於去年 7 月宣佈,印尼在協議前面臨高達 32% 的關税威脅。協議內容包括豁免美國企業遵守自製率規定,並解決美國農產品在印尼的貿易障礙。此外,印尼同意採購價值 330 億美元的美國能 | [Link](https://longbridge.com/en/news/276423471.md) | | 若不剔除淨零議程 美揚言退出 IEA | 美國能源部長萊特在 IEA 部長級會議上表示,若不在一年內將「淨零排放」目標移除,美國將退出國際能源總署(IEA)。他稱「淨零排放」是「帶有毀滅性的幻想」,並強調 IEA 應回歸確保能源安全的初衷。此次會議未能發表最終公報,僅發布「主席摘要 | [Link](https://longbridge.com/en/news/276472598.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.